Ranibizumab frente a bevacizumab. Consideraciones farmacológicas
Ranibizumab versus bevacizumab. Pharmacological considerations
Leído
3604
Vecesse ha leído el artículo
602
Total PDF
3002
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 5 | 1 | 1 | 2 |
| 2023 3 | 2 | 0 | 2 |
| 2020 10 | 1 | 0 | 1 |
| 2020 6 | 0 | 2 | 2 |
| 2019 9 | 18 | 0 | 18 |
| 2019 4 | 1 | 0 | 1 |
| 2018 3 | 5 | 0 | 5 |
| 2018 2 | 22 | 6 | 28 |
| 2018 1 | 21 | 1 | 22 |
| 2017 12 | 30 | 1 | 31 |
| 2017 11 | 60 | 4 | 64 |
| 2017 10 | 52 | 8 | 60 |
| 2017 9 | 43 | 9 | 52 |
| 2017 8 | 50 | 1 | 51 |
| 2017 7 | 59 | 3 | 62 |
| 2017 6 | 61 | 14 | 75 |
| 2017 5 | 62 | 7 | 69 |
| 2017 4 | 70 | 7 | 77 |
| 2017 3 | 66 | 20 | 86 |
| 2017 2 | 105 | 8 | 113 |
| 2016 1 | 71 | 0 | 71 |
| 2016 12 | 66 | 10 | 76 |
| 2016 11 | 91 | 9 | 100 |
| 2016 10 | 106 | 15 | 121 |
| 2016 9 | 88 | 7 | 95 |
| 2016 8 | 72 | 5 | 77 |
| 2016 7 | 48 | 4 | 52 |
| 2016 6 | 56 | 22 | 78 |
| 2016 5 | 64 | 21 | 85 |
| 2016 4 | 45 | 15 | 60 |
| 2016 3 | 55 | 15 | 70 |
| 2016 2 | 60 | 12 | 72 |
| 2015 1 | 37 | 15 | 52 |
| 2015 12 | 38 | 21 | 59 |
| 2015 11 | 45 | 14 | 59 |
| 2015 10 | 68 | 18 | 86 |
| 2015 9 | 63 | 12 | 75 |
| 2015 8 | 65 | 7 | 72 |
| 2015 7 | 56 | 7 | 63 |
| 2015 6 | 38 | 7 | 45 |
| 2015 5 | 57 | 8 | 65 |
| 2015 4 | 44 | 25 | 69 |
| 2015 3 | 60 | 17 | 77 |
| 2015 2 | 48 | 9 | 57 |
| 2015 1 | 36 | 7 | 43 |
| 2014 12 | 68 | 11 | 79 |
| 2014 11 | 57 | 10 | 67 |
| 2014 10 | 51 | 23 | 74 |
| 2014 9 | 51 | 29 | 80 |
| 2014 8 | 22 | 6 | 28 |
| 2014 7 | 33 | 12 | 45 |
| 2014 6 | 34 | 7 | 41 |
| 2014 5 | 28 | 9 | 37 |
| 2014 4 | 23 | 15 | 38 |
| 2014 3 | 26 | 11 | 37 |
| 2014 2 | 36 | 13 | 49 |
| 2014 1 | 31 | 14 | 45 |
| 2013 12 | 45 | 21 | 66 |
| 2013 11 | 46 | 10 | 56 |
| 2013 10 | 46 | 7 | 53 |
| 2013 9 | 24 | 5 | 29 |
| 2013 8 | 28 | 4 | 32 |
| 2013 7 | 9 | 1 | 10 |
| 2013 6 | 1 | 0 | 1 |
| 2012 12 | 137 | 0 | 137 |
Mostrar todo
